Gabapentin Tablet
Product Images NDC 50228-178

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50228-178). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin 100mg 30s

Label for Gabapentin Capsules, USP 100 mg by ScieGen Pharmaceuticals, Inc. The label includes dosage instructions, storage conditions (20° to 25°C), dispensing info, and cautions for child-resistant packaging. The package contains 30 capsules and is marked Rx Only. Manufacturer and barcode details are present.*

FDA Label Image

Gabapentin 100mg 1000cap

Gabapentin Capsules USP 100 mg oral capsules label from ScieGen Pharmaceuticals Inc. The label indicates the package contains 1,000 capsules and includes storage instructions, usage direction to provide a Medication Guide, and child-resistant closure information. The label also displays the NDC 50228-179-10 and a barcode.*

FDA Label Image

Gabapentin 100mg 100cap

Label for Gabapentin Capsules USP 100 mg by ScieGen Pharmaceuticals, Inc. The label indicates the package contains 100 capsules for oral use. It includes storage instructions, dispensing requirements, and a barcode. The panel shows the NDC number and states 'NO VARNISH' in orange text on the right side.*

FDA Label Image

Gabapentin 100mg 500cap

Gabapentin Capsules USP 100 mg oral capsules package label from ScieGen Pharmaceuticals, Inc. The label indicates 500 capsules per container, includes NDC 50228-179-05, and provides storage and usage information. The design includes a barcode and notes that the capsules are prescription-only.*

FDA Label Image

Gabapentin 300mg 30s

Gabapentin Capsules, USP 300 mg oral capsules label from ScieGen Pharmaceuticals, Inc. The label indicates a 30-capsule package with dispensing instructions, storage conditions, and a barcode. It includes a note for pharmacists to provide a Medication Guide with dispensing and states the product is prescription only.*

FDA Label Image

Gabapentin 300mg 1000cap

Label for Gabapentin Capsules USP 300 mg, an oral capsule dosage form. The label states 1,000 capsules per container, with storage instructions between 20° to 25°C and permitted excursions from 15° to 30°C. The product is labeled for prescription use only and manufactured by ScieGen Pharmaceuticals, Inc. Includes drug quantity and pharmacist medication guide notice.*

FDA Label Image

Gabapentin 300mg 100cap

Gabapentin Capsules, USP 300 mg label from ScieGen Pharmaceuticals, Inc. The label includes the NDC, a 100 capsule count, directions for pharmacists to provide a Mediation Guide, storage instructions, and a barcode. The label also notes the product is Rx only and the container features a child-resistant closure.*

FDA Label Image

Gabapentin Capsules, Usp 300 mg (500 capsules label)

Gabapentin Capsules USP 300 mg oral capsules, containing 500 capsules per container, labeled by ScieGen Pharmaceuticals, Inc. The label includes storage instructions, dispenser warnings about child-resistant closure, and pharmacist guidance for patient Mediation Guide provision. NDC 50228-180-05 is visible on the label.*

FDA Label Image

Gabapentin 400mg 30s

Label for Gabapentin Capsules, USP 400 mg by ScieGen Pharmaceuticals, Inc. The label includes dosage form (capsules), strength (400 mg), packaging count (30 capsules), storage instructions, and a barcode. The label also states it is a prescription drug and includes the NDC number 50228-181-30.*

FDA Label Image

Gabapentin 400mg 100cap

Label for Gabapentin Capsules, USP, 400 mg by ScieGen Pharmaceuticals, Inc. The label indicates the product contains 100 capsules for oral use, is prescription only, and includes storage instructions and a pharmacist medication guide notice. The label also features the NDC 50228-181-01 and a barcode.*

FDA Label Image

Gabapentin Capsules, Usp 400 mg (500 capsules label)

Gabapentin Capsules USP 400 mg label from ScieGen Pharmaceuticals Inc. It specifies 500 capsules per container with usage instructions, storage conditions, and a barcode. The label highlights the 400 mg strength and includes pharmacist and prescription information along with the NDC 50228-181-05.*

FDA Label Image

Gabapentin 600mg 30s

Gabapentin Tablets, USP 600 mg oral film-coated tablets label by ScieGen Pharmaceuticals, Inc. The label states each tablet contains 600 mg gabapentin and includes storage instructions. It indicates a package of 30 tablets, prescription use only, with a barcode and manufacturer details from ScieGen Pharmaceuticals, Hauppauge, NY.*

FDA Label Image

Gabapentin 600mg 100tab

Gabapentin Tablets USP 600 mg oral tablet bottle label from ScieGen Pharmaceuticals, Inc. The label states 100 tablets per bottle and includes dispensing guidance for pharmacists as well as storage instructions. The label features a barcode and the NDC number 50228-177-01.*

FDA Label Image

Gabapentin Tablets, Usp 600 mg (500 Tablets label)

The packaging label for Gabapentin Tablets USP, 600 mg strength, oral tablets, with a container size of 500 tablets. The label indicates the product is prescription-only and manufactured by ScieGen Pharmaceuticals, Inc. Additional text includes dispensing instructions, storage conditions, and a barcode.*

FDA Label Image

Gabapentin 800mg 30s

Label for Gabapentin Tablets USP, 800 mg, produced by ScieGen Pharmaceuticals, Inc. The oral film-coated tablets come in a package of 30. The label includes storage instructions, dosage caution, and a barcode, with a clear display of the product name and strength.*

FDA Label Image

Gabapentin 800mg 100tab

Gabapentin Tablets, USP 800 mg oral tablets in a 100-count package by ScieGen Pharmaceuticals, Inc. The label includes dosage information and a note for pharmacists to provide a medication guide to patients. A barcode and manufacturer details are also visible.*

FDA Label Image

Gabapentin Tablets, Usp 800 mg (500 Tablets label)

Gabapentin Tablets, USP 800 mg oral tablets packaging label from ScieGen Pharmaceuticals, Inc. The label shows the strength of 800 mg, contains 500 tablets, and is labeled for prescription use only (Rx only). Storage and dispensing instructions and a barcode are also visible.*

FDA Label Image

Image 01

A line graph depicting the mean pain score over an 8-week period comparing placebo to Gabapentin 3600 mg/day. The x-axis represents weeks, divided into a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows the mean pain score decreasing more notably with Gabapentin than placebo.*

FDA Label Image

Image 02

A line graph depicting mean pain scores over 7 weeks during a 3-week dose titration period followed by a 4-week fixed dose period. The graph compares placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day, showing a decline in mean pain scores for Gabapentin groups compared to placebo over time.*

FDA Label Image

Image 03

A bar chart titled "Figure 3. Proportion of Responders (patients with 60% reduction in pain score) at Endpoint: Controlled PHN Studies." It compares proportions of responders between placebo (PBO) and gabapentin (GBP) at doses of 1800, 2400, and 3600 mg across two studies, with percentages and statistical significance indicated.*

FDA Label Image

Cockcroft And Gault Equation (Image 04)

A formula illustrating the calculation of creatinine clearance (CLCr) based on age, weight, and serum creatinine levels, with an adjustment factor for female patients. It is related to pharmacokinetic parameters relevant to drug dosing.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of the active ingredient Gabapentin, showing a cyclohexane ring attached to an amino group and a carboxymethyl group. The diagram depicts the molecular arrangement and connectivity of Gabapentin.*

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Image 09)

A scatter plot chart showing the percentage difference on the y-axis against daily dose in milligrams on the x-axis (600, 900, 1200, 1800 mg). It compares three studies labeled a, b, and c, represented by different square markers. The chart depicts differences at varying daily doses of gabapentin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.